TEA

Official title: Tolerance and effect of antipsychotics in children and adolescents with psychosis - An investigator-initiated, phase IV, randomised double-blind multi-centre trial of the benefits and harms of aripiprazole versus quetiapine in children and adolescents with psychosis

Trial start year: 2010

Trial website

No website available

Trial registration

NCT01119014
View registration
Design paper

Design paper

2014

Quetiapine versus aripiprazole in children and adolescents with psychosis - protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial
Download full paper
Result paper

Result paper

2017

Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial
Download full paper